Results of Combined Medical and Swallowing Behavioral Readjustment Therapy in Oropharyngeal Dysphagia Management Among Parkinson's Patients
NCT07618637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2026-06-01
Summary
The study aims to assess the efficacy of using swallowing behavioral readjustment technique in combination with medical treatment in management of oropharyngeal dysphagia among Parkinson's patients in order to improve the management protocol
Conditions
- Oropharyngeal Dysphagia (OPD)
- Parkinson
- Swallowing Difficulties
Interventions
- BEHAVIORAL
-
combined pharmaceutical treatment and rehabilitation techniques
Group (A) managed by combined pharmaceutical treatment and rehabilitation techniques for 6 months .
- DRUG
-
pharmaceutical treatment only
Group (B) managed by pharmaceutical treatment only
Sponsors & Collaborators
-
Tanta University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-08-30
- Primary Completion
- 2024-08-30
- Completion
- 2024-08-30
Countries
- Egypt
Study Locations
More Related Trials
-
Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
NCT00624741 ·Status: NO_LONGER_AVAILABLE
-
A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease
NCT01370811 ·Status: COMPLETED ·Phase: PHASE2
-
Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
NCT02589340 ·Status: TERMINATED ·Phase: PHASE1
-
Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients
NCT02763137 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease
NCT05576818 ·Status: RECRUITING ·Phase: PHASE3
-
Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing- A Comparative Effectiveness Study
NCT01476306 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Subclinical and Clinical Dysphagia in Parkinson's Disease
NCT04889170 ·Status: COMPLETED
-
Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease
NCT00758368 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON
NCT02769793 ·Status: COMPLETED ·Phase: PHASE4
-
Sustained Release Oral Formulation For Treatment Of Parkinsons Disease
NCT07709741 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Predictors of Parkinson's Disease Progression
NCT04062279 ·Status: UNKNOWN
-
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
NCT01429207 ·Status: COMPLETED
-
Comparison of Dopamin Level in Idiopathic Parkinson's Patients
NCT06115538 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients
NCT01229332 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of Stellate Ganglion Block in Individuals With Parkinson's Disease
NCT06301724 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Metformin in Parkinson Disease
NCT07229651 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Pharmacokinetic Study in Healthy Volunteers
NCT02554734 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Effects of Mannitol in Parkinson's Disease
NCT03823638 ·Status: UNKNOWN ·Phase: PHASE2
-
Determining Clinical Profile of Parkinson's Disease Among Egyptian Population
NCT02785510 ·Status: UNKNOWN
-
Non Motors Aspects in De Novo Parkinson's Disease
NCT02786667 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers
NCT01486628 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
NCT00558337 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease
NCT02577523 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease
NCT02111122 ·Status: COMPLETED ·Phase: PHASE2
-
Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
NCT00467597 ·Status: COMPLETED